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KEY POINTS SUMMARY 
• We have developed novel techniques for paired, direct, real-time in vivo quantification of 
endothelial glycocalyx structure and associated microvessel permeability 
• Commonly used imaging and analysis techniques yield measurements of endothelial 
glycocalyx depth that vary by over an order of magnitude within the same vessel 
• The anatomical distance between maximal glycocalyx label and maximal endothelial cell 
plasma membrane label provides the most sensitive and reliable measure of endothelial 
glycocalyx depth 
• Sialic acid residues of the endothelial glycocalyx regulate glycocalyx structure and 
microvessel permeability to both water and albumin 
 
ABSTRACT 
The endothelial glycocalyx forms a continuous coat over the luminal surface of all vessels, and 
regulates multiple vascular functions. The contribution of individual components of the endothelial 
glycocalyx to one critical vascular function, microvascular permeability, remains unclear. We 
developed novel, real-time, paired methodologies to study the contribution of sialic acids within the 
endothelial glycocalyx to the structural and functional permeability properties of the same 
microvessel in vivo. Single perfused rat mesenteric microvessels were perfused with fluorescent 
endothelial cell membrane and glycocalyx labels, and imaged with confocal microscopy. A broad 
range of glycocalyx depth measurements (0.17–3.02μm) were obtained with different labels, 
imaging techniques and analysis methods. The distance between peak cell membrane and peak 
glycocalyx label provided the most reliable measure of endothelial glycocalyx anatomy, correlating 
with paired, numerically smaller values of endothelial glycocalyx depth (0.078±0.016μm) from 
electron micrographs of the same portion of the same vessel. Disruption of sialic acid residues 
within the endothelial glycocalyx using neuraminidase perfusion decreased endothelial glycocalyx 
depth and increased apparent solute permeability to albumin in the same vessels in a time-
dependent manner, with changes in all three true vessel wall permeability coefficients (hydraulic 
conductivity, reflection coefficient, and diffusive solute permeability). These novel technologies 
expand the range of techniques that permit direct studies of the structure of the endothelial 
glycocalyx and dependent microvascular functions in vivo, and demonstrate that sialic acid 
residues within the endothelial glycocalyx are critical regulators of microvascular permeability to 
both water and albumin. 
 
(242 words) 
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ABBREVIATIONS 
 
Alexa488   Alexa Fluor 488™  
ANOVA   analysis of variance  
BSA   bovine serum albumin  
FITC   fluorescein isothiocyanate  
LED   light emitting diode 
PMT   photomultiplier tube 
Ps BSA  Apparent solute permeability to bovine serum albumin 
R18    Octadecyl Rhodamine B Chloride 
SIP   sphingosine-1-phosphate 
TRITC  Trimethylrhodamineisothiocyanate 
TMA-DPH  1-(4-Trimethylammoniophenyl)-6-phenyl-1, 3, 5-hexatriene p-toluenesulfonate 
WGA  wheat germ agglutinin 
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INTRODUCTION 
 
The entire luminal surface of all vascular walls is covered with a continuous, carbohydrate-rich 
mesh: the endothelial glycocalyx (Weinbaum et al., 2007). The membrane-bound portion of the 
endothelial glycocalyx is supplemented with components of plasma to form a thickened endothelial 
surface layer. This endothelial coat governs the nature of interactions between fluid, protein and 
cellular constituents of flowing blood and the endothelial cell, and is therefore a critical regulator of 
vascular function (Curry & Adamson, 2013). The endothelial glycocalyx regulates permeability in 
exchange microvessels; leukocyte rolling, adhesion and migration in post-capillary venules; 
mechanotransduction, flow- and shear-induced vasodilation in arterioles, and protects the vessel 
wall from the development of atherosclerosis in conduit arteries.  
 
The role of the endothelial glycocalyx in regulating microvessel permeability was formalised in the 
fibre-matrix junction-break theory proposed by Curry and Michel in 1980 (Curry & Michel, 1980). 
This theory and subsequent refinements hold that the endothelial glycocalyx is the primary 
macromolecular sieve in continuous microvessels, and that this sieving immediately above 
interendothelial junctions creates a protected "sub-glycocalyx space", whose oncotic pressure 
determines the magnitude of the oncotic pressure gradient resisting water and solute flux across 
vessel walls (Levick & Michel, 2010). Demonstrations of the resulting non-linear form of the 
Starling equation under steady-state filtration conditions (Michel & Phillips, 1979), and unequal 
actions of luminal and abluminal oncotic pressures (Hu et al., 2000), support this theory. These 
functional demonstrations are supported by recent observations that a repeating periodic 
arrangement of the fibres of the endothelial glycocalyx are sufficient to explain the near-uniform 
macromolecular permeability coefficients seen throughout the vasculature (Squire et al., 2001; 
Arkill et al., 2011). The endothelial glycocalyx also regulates hydraulic resistance, with greater 
glycocalyx depths providing greater resistance (Adamson, 1990; Salmon et al., 2009). 
 
The structure of the endothelial glycocalyx is complex, with depth, spatial localisation and 3D 
architecture all structural facets that impact on vascular function including permeability. In addition, 
determining the relative functional importance of different glycocalyx components has been 
challenging. The endothelial glycocalyx contains an array of glycoproteins, proteoglycans and 
glycosaminoglycans (GAGs), with much focus on the importance of GAGs in regulating key 
physiological properties to the vessel wall (Tarbell & Ebong, 2008). Many of the glycoproteins are 
capped by sialic acid (Varki, 2008) contributing to the structure of the glycocalyx.  The dominant 
GAG is heparan sulphate, which is a family of charged molecules with a wide variety of subtypes 
depending on the nature of bonds between individual saccharide units and their sulphation pattern 
(Weinbaum et al., 2007)). Heparan sulphate has been shown to regulate mechanotransduction 
(Florian, 2003; Kumagai et al., 2009), and evidence indicates an important role in regulating 
permeability in endothelial monolayers in vitro (Singh et al., 2007) and in isolated coronary 
arterioles ex vivo (Huxley & Williams, 2000). Chondroitin sulphate also carries significant charge, 
and again appears to have an important role in regulating permeability (Jeansson & Haraldsson, 
2003). Finally hyaluronan, a non-sulphated GAG with extended chain length, also plays important 
roles in mechanotransduction and glomerular filtration (Jeansson et al., 2006; Pahakis et al., 2007; 
Jeansson et al., 2009). 
 
At present, little is known about the potential role that sialic acid residues within the endothelial 
glycocalyx may also make to microvessel permeability characteristics. Sialic acid residues 
regulate leukocyte (Sakarya et al., 2004) and platelet (Gorog et al., 1982) adhesion, 
mechanotransduction (Tarbell & Ebong, 2008; Kumagai et al., 2009), LDL uptake into endothelial 
cells (Gorog et al., 1982) and development of atherosclerosis (Cuniberti et al., 2005). Endothelial 
glycocalyx sialic acid residues are disrupted in disease states predisposing to atherosclerosis such 
as diabetes (Nassimizadeh et al., 2010), as well as playing an important role in kidney disease 
(Dekan et al., 1991; Gelberg et al., 1996), and sepsis (Adembri et al., 2011), all of which have 
been linked to endothelial glycocalyx dysfunction (Salmon & Satchell, 2012). Despite this, the role 
 5
of sialic acids in regulating microvessel permeability remains unclear. Early studies showed no 
change in microvessel permeability following sialic acid disruption by neuraminidase (Mason et al., 
1977). In vitro studies indicate a role for sialic acid residues in endothelial cell monolayer barrier 
function (Singh et al., 2007; Cioffi et al., 2012), but the endothelial glycocalyx and permeability 
coefficients of cultured endothelial cells are substantially different from the in vivo situation (Curry, 
2005; Chappell et al., 2009). Despite their abundance and importance in key physiological 
processes and disease states, the importance of endothelial glycocalyx sialic acid residues in 
regulating intact vessel wall permeability coefficients remains unclear.  
 
Current in vivo studies of the endothelial glycocalyx either involve disruptive (e.g. electron 
microscopy) or indirect (e.g. tracer exclusion) techniques to examine the endothelial glycocalyx, 
both of which give conflicting results (Salmon et al., 2009; Gao & Lipowsky, 2010). Newer and 
more direct optical imaging techniques which have employed the use of fluorescently tagged 
antibodies and lectins to bind glycocalyx have also been attempted in recent years (Cai et al., 
2012; Salmon et al., 2012; Yen et al., 2012). These techniques have often used confocal laser 
scanning and two-photon microscopes in an attempt to better resolve the glycocalyx in 
microvessels. However, even with the improved resolution of laser scanning methods, these 
optical techniques are still assessing changes in glycocalyx structure that fall within or below the 
difraction limit of optical imaging, particularly in the physiological environment (Gretz & Duling, 
1995). To make estimates of relative changes in depth within this resolution limit, each of these 
direct optical imaging techniques have applied different analysis methods which often yield varying 
and conflicting results (Gao & Lipowsky, 2010; Cai et al., 2012; Salmon et al., 2012; Yen et al., 
2012). In addition, these studies of endothelial glycocalyx are rarely coupled with measurements 
of the functional properties of the wall of the same vessel.  
 
The aim of this study was to understand the contribution of endothelial glycocalyx sialic acid 
residues to microvascular structure and permeability function, and to do so we have developed 
methods for real-time, direct, paired measurements of endothelial glycocalyx structure and 
function in vivo, as well as applying electron microscopy preservation to compare in vivo and ex 
vivo measurements of the same vessels with known functional properties.  
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METHODS 
 
Ethical approval  
Procedures were carried out in accordance with national regulations set out by the UK Home 
Office legislation, and with local approval from the University of Bristol local ethical committee. 
Male Sprague-Dawley rats (150-250g; Harlan) were used in all experiments. Anaesthesia was 
induced with an intraperitoneal injection of sodium pentobarbital (60 mg/kg), and maintained with 
subcutaneous intramuscular injections approximately every 45 minutes. At the end of all 
experiment animals, were euthanased with excess anaesthetic and cervical dislocation. 
Glycocalyx measurements were made on 16 rats, solute permeability measurements on 9 rats, 
and hydraulic conductivity and reflection coefficient measurements on 7 rats.  
 
Real-time endothelial glycocalyx imaging 
Under anaesthesia, the mesentery was exposed via a midline laparotomy, constantly superfused 
with mammalian Ringer solution at 37 °C, teased over a glass coverslip, and imaged via the 
objective of an inverted microscope. Capillaries and post-capillary venules from 10-40 µm in 
diameter and without rolling or adherent leukocytes were identified, and cannulated in the direction 
of flow with a refillable bevelled glass micropipette (Bates, J Anat, 2002) for endothelial glycocalyx 
imaging alone in initial experiments. Microvessels were then perfused continuously with 
mammalian Ringer solution containing BSA (4%; A4378, Sigma), followed by supplementation 
with an endothelial cell membrane label (Octadecyl rhodamine B chloride (R18) (2 µM in BSA-
Ringer-0.01%DMSO; O246, Life Technologies), or TMA-DPH (2 µM in BSA-Ringer-0.01%DMSO; 
T204, Molecular Probes) (Peti-Peterdi et al., 2009) and then labelling of sialic acid residues within 
the endothelial glycocalyx (FITC-conjugated WGA (2 mole/mole dye content; 2.77 µM in BSA-
Ringer;L4895, Sigma) or TRITC-conjugated WGA (0.65 mole/mole dye content; 11.08 µM in BSA-
Ringer; L5266, Sigma), with concentrations determined in preliminary optimisation experiments, 
each for 5 minutes, followed by washout with unsupplemented 4% BSA-Ringer solution. 
 
Respiratory and peristaltic movement required both fluorophores (R18 and FITC-WGA) to be 
excited and detected simultaneously in all experiments. The consequent theoretical possibility of 
signal detection in the 605±75nm (R18) channel from the broad emission spectrum of WGA-
conjugated FITC was assessed qualitatively and quantitatively.  Fluorescein (FITC-WGA) artefacts 
observed in the centre of vessels were detected in both the 515±30nm (FITC) and 605±75nm 
(R18) channels. Due to simultaneous dual colour fluorescence collection overlap of the R18 
emission with the 488 laser can be significant therefore other fluorophores used in combine 
glycocalyx-permeability studies (FITC-WGA and alexa-488 BSA) also required assessment of 
alternative glycocalyx and endothelial cell membrane labels. Endothelial glycocalyx depth was 
therefore also measured using TRITC-WGA (to label sialic acid residues in the endothelial 
glycocalyx), and TMA-DPH (to label endothelial cell membrane), with neither fluorophore emission 
spectra detectable by an alternative channel. This combination of TMA-DPH (endothelial cell 
membrane) and TRITC-WGA (sialic acid residues in the endothelial glycocalyx) also eliminated 
the possibility of fluorescent emission from anatomical labels from confounding the functional 
solute flux data obtained using Alexa 488 BSA in later experiments. 
 
Labelled mesenteric microvessels were imaged via the objective (CFI Plan Apochromatic VC 60X 
Oil with 1.4 NA) of an inverted microscope (Nikon eclipse TiE), and scanned in the x and y 
directions using 488 nm and 543.3 nm wavelength lasers (100% laser power). The laser power, 
gain and offset for both channels was kept constant for all experiments (515±30 nm channel = 90 
gain & 0 offset; 605±75 nm = 100 gain & 0 offset). Fluorescent light emitted back into the objective 
was detected using 515±30 nm and 605±75 nm photomultiplier tubes (PMT), and differential 
interference contrast (DIC) images were detected simultaneously in a diascopic manner using a 
PMT for transmitted light. Z-stack images (2048 by 2048 pixels; 20-slices), were captured through 
the entire vessel using an even inter-slice distance in proportion to the height of the vessel being 
imaged (e.g. a 20 µm diameter vessel will have 20 optical slices each 1 µm apart) (Figure 1A). 
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Endothelial glycocalyx image analysis 
All z stacks were analysed using FIJI (Image J) software (Schindelin et al., 2012). Three channels 
(DIC, endothelial glycocalyx label (FITC or TRITC), & cell membrane label (R18 or TMA-DPH 
channels)) and 20 slices in the z plane were processed to account for variability in the image 
acquisition step, predominantly arising from respiratory and peristaltic movement between optical 
slices of the z-stacks causing misalignment of frames within a z-stack. Virtual stack slices were 
therefore registered based on the images acquired in the DIC channel, and realigned identically 
for all channels to generate a three dimensional image of the entire vessel. Once registered, the z-
stack image demonstrating the maximal vessel diameter (i.e. the mid-point of the vessel, and the 
position in which endothelial glycocalyx and cell membrane labels will be perpendicular to the 
plane of section, minimising anatomical overlap) was identified (Figure 1A, red arrow). 
Fluorescence intensity profiles were then generated for both endothelial cell label and sialic acid 
component of the endothelial glycocalyx label, along 30 evenly-spaced lines across the full width 
of the vessel. Each point along the profile represented the average fluorescence intensity from 16 
adjacent pixels (8 pixels either side of the line drawn) (Figure 1B). Four automated measurements 
of endothelial glycocalyx parameters were then calculated (Figure 1C): i) the anatomical distance 
between peak signal intensity of the endothelial cell membrane label and sialic acid component of 
the endothelial glycocalyx label (“peak to peak”); ii) the full width measured at the point of half 
maximal fluorescence intensity of the sialic acid component of the endothelial glycocalyx label 
(“FWHM”); iii) and the peak fluorescence intensity of the sialic acid component of the endothelial 
glycocalyx label  (If). Mean values for each of these three assessments of the endothelial 
glycocalyx were then determined using data from all of the 30 intensity lines analysed; any values 
for peak to peak which yielded depth values of ≤0 were excluded from the calculation of the mean 
glycocalyx depth, and were used to determine (iv) a fractional coverage of positively (and 
negatively) resolvable glycocalyx. All registration, maximal width identification, fluorescence 
intensity profiling and measurement steps were conducted by automated macros.  
 
To model whether the peak to peak method was dependent on the size of the individual picture 
elements acquired in the image we used computational modelling to varying the anatomical 
position of the “true” theoretical peak glycocalyx within a single voxel by passing an Airy disk 
representation of 488nm laser light passing through a 1.4NA objective (Figure 1D) at 1nm 
intervals. The anatomical position of the maximum intensity reading would vary as much as one 
voxel integer (104 nm for the 60x objective). This problem was addressed mathematically by 
comparing the recorded peak intensity with those calculated to be close to the true intensity via 
linear interpolation (triangulation) and Gaussian fitting of the 3 peak pixels recorded (Figure 1E). 
Results showed that recorded peak intensities and triangulated peak intensities varied depending 
on the true position, but Gaussian intensities provided the least variable (mid-range) results, with 
the position of peak fluorescence intensity identified independent of the starting point of the scan, 
therefore providing the greatest anatomical resolution of these 3 methods. (Figure 1E). As a 
consequence, all further measurements were calculated using the peak value of a Gaussian fit of 
recorded peak intensities. 
 
Paired imaging of solute flux and endothelial glycocalyx 
Having developed imaging methods for studying the endothelial glycocalyx in real time in vivo, 
alternative cannulation and perfusion systems were necessary and hence developed for combined 
solute permeability and endothelial glycocalyx imaging (figure 2A). Micropipettes were constructed 
in house from split-barrel borosilicate glass capillaries (O.D. 2 mm, wall thickness 0.3 mm, central 
septum thickness 0.22 mm), pulled to a fine tip (Narishige P22), bevelled (25° angle, 10-15 µm tip 
diameter), and angled mid-shaft (~45° angle). Each pipette barrel then received a refilling line 
(stretched polyethylene tubing, O.D. 0.61 mm) and a blunt-tipped needle (26G), before the non-
cannulating rear aperture was sealed with epoxy resin. The refill line was connected to a syringe 
pump-driven replaceable refill reservoir for exchanging solutions within each pipette barrel; the 
26G needles were attached to individual, modifiable water manometers to control hydrostatic 
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pressures in each side of the pipette independently (Figure 2A). 
Using the same surgical preparation described above for glycocalyx-only imaging, mesenteric 
microvessels were cannulated using this double-barrelled pipette system. Barrel A contained BSA-
Ringer solution (final concentration 4% w/v BSA). Barrel B contained BSA-Ringer solution 
supplemented with Alexa Fluor 488 conjugated BSA (Alexa 488 BSA; 0.03 mg/ml unless 
otherwise stated) to a final concentration of 4% w/v total BSA. Following cannulation, the 
pressures exerted individually to both pipette barrels were adjusted manually using the relevant 
water manometers until balance pressure was reached (perfusion ceased; typical range 15-25 
cmH2O). The pressure in barrel A (BSA-Ringer) was then marginally raised (1-5 cmH2O) above 
the pressure in barrel B (Alexa 488 BSA) until the vessel was perfused with BSA-Ringer only, 
without backflow into barrel B. The vessel was continuously perfused under these stable 
conditions for 10min before image acquisition. 
 
The entire imaging window was excited at 480 nm using a widefield fluorescent LED (Precise 
Excite Cool LED; 50% power). Emitted fluorescence was filtered through a 535 nm filter block and 
focused onto the sensor of a high sensitivity camera (Photometrics CoolSnap HQ2; fixed settings: 
14-bit monochrome detection; 20 MHz readout mode; 2x2 binning; 696 x 520 pixels; 350 visual 
gain). Under these conditions, initial videos were captured (Nikon NIS Elements software; 60 ms 
intervals; 20 s duration). Pressures in barrels A and B were then instantly swapped, halting 
perfusion of BSA-Ringer and commencing perfusion with Alexa 488 BSA (figure 2B, C). After 20s 
perfusion with fluorescent solution, pressures were switched back to initial settings, generating 
perfusion with non-fluorescent BSA-Ringer for a final period of 20s (figure 2C). This perfusion and 
imaging sequence for capturing solute permeability (PsBSA) quantification data was repeated 4-5 
times for each period of the experiment. During these experimental periods, perfusate either 
contained vehicle, or neuraminidase to disrupt sialic acids (Neuraminidase from Clostridium 
perfringens (Salmon et al., 2012); 2 U/ml in 4% BSA; N2876, Sigma). 
 
Following this imaging of solute flux, pipette barrels A and B were refilled and the vessel perfused 
with labels for endothelial cell membrane and glycocalyx: note that the use of Alexa-488-labelled 
BSA precluded the use of overlapping emission fluorophores (e.g. FITC) for cell membrane or 
glycocalyx labelling in these permeability experiments. After PsBSA measurements, vessels were 
therefore labelled with TMA-DPH to label endothelial cell membranes; and TRITC-WGA to label 
endothelial glycocalyx sialic acid residues; Figure 2D). Each dye was perfused for 5 minutes, 
before lumen refill and perfusion with BSA-Ringer alone. Endothelial glycocalyx was then imaged 
as described above (Figure 2E).  
 
Solute permeability analysis 
Real time video images of Alexa 488 BSA perfused microvessels were analysed using Nikon NIS 
Elements software. A standard Region of Interest (ROI) was created, covering the full length of the 
perfused vessel in the imaging field and extending 20um directly adjacent to either side of the 
vessel, with the distance between pipette tip and the ROI position maintained at ~150 µm. ROI 
measurements of mean fluorescence intensity (If) vs time (s) were recorded from each experiment 
and plotted as a scatter plot giving a characteristic time course appearance (e.g. Figure 2C). 
Anatomical dimensions of the microvessel radii (r) were measured directly from images of 
endothelial cell membrane labelling in the same microvessel. 
A typical time course plot (e.g. Figure 2C) demonstrated a steady baseline value of background 
fluorescence intensity (If) during perfusion of just BSA-ringer alone. Initial filling of the vessel 
lumen with Alexa 488 BSA caused a sharp, stepwise increase in fluorescence intensity (If; [ΔIf]0)). 
Initial BSA transport across the vessel wall caused a steady rate increase in If over time ([dIf/dt]0) 
(Figure 2C; white line), followed by a sudden drop in If when the perfusate was switched back to 
BSA-Ringer. 
The permeability coefficient of the solute BSA (PsBSA) was the rate of flux of BSA (Js BSA) through 
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an area of a microvessel (A) per unit concentration difference (Δc). This can be expressed as: 
Equation 1.1   PsBSA = JsBSA
A



.
1
Δc
 
With this methodology (Huxley et al., 1987), Js BSA could be calculated from the initial stepwise 
change (ΔIf) and subsequent rate of change fluorescence intensity (dIf) over time (t) immediately 
(time zero: “0”) after the capillary lumen was filled with Alexa 488 BSA in a capillary of measured 
radius (r): 
Equation 1.2   PsBSA = 1
ΔIf 0
. dIf
dt



0 .
r
2  
 
Endothelial glycocalyx imaging by electron microscopy 
Following real time structural measurements of glycocalyx and vessel permeability in vivo, vessels 
were then perfused with albumin-free Alcian Blue-Ringer solution (Alcian blue 8GX, A5268, 
Sigma) as previously described (Salmon et al., 2009) for 5 minutes (Figure 2F). Superfusate was 
then switched from warm Ringer to ice cold glutaraldehyde (2.5%) for 5 minutes to achieve 
mesentery stiffening indicating successful fixation. Micropipettes were then removed, the 
mesenteric panel containing the preserved vessel dissected away from the surrounding gut, rinsed 
and then stored in glutaraldehyde at 4°C. Specimens were post fixed using 1% osmium tetroxide, 
1% lanthanum chloride and saturated uranyl acetate on ice, and then processed and embedded 
into resin. The cannulation site in the microvessel studied in vivo was identified, and the block was 
trimmed until 100nm sections containing the previously studied portion of mesenteric microvessel 
were cut, mounted on piloform covered slot grids, and imaged with 120keV transmission electron 
microscopy (Tecnai T12 with an Eagle camera (FEI)) (Figure 2Fiii).  
 
Electron micrographs were analysed using Adobe Photoshop software. Images from 8 points 
evenly spaced around the lumen were assessed to quantify glycocalyx depth in each of these 
regions. The depth was assessed at 20 points for each high power image by measuring the 
anatomical distance from the luminal phospholipid bilayer to the furthest point of glycocalyx; 
perpendicular measurements were assured by only using images where the phospholipid bilayer 
was visible as two distinct layers. This was performed by initially overlaying a grid, and depth was 
measured at any point where the visible phospholipid bilayer crossed vertical or horizontal lines 
(depending on the orientation of the image). Sample groups were blinded before analysis, and 
measurements performed at points where endothelial cell membranes touched the overlaid 
gridlines to eliminate potential subjective interpretations. 
 
Hydraulic conductivity and reflection coefficient measurement 
In separate experiments, we used the Landis–Michel micro-occlusion technique as previously 
described to measure permeability coefficients hydraulic conductivity (LP) and the reflection 
coefficient to albumin (σBSA), in intact microvessels in vivo (Salmon et al., 2009).  
In the steady state the following holds (Michel and Phillips 1987): 
 
Equation 2.1  ௃ೡ஺ =  ܮ௣(ΔP −  ߪଶΠ௖) 
 
Individual mesenteric microvessels were exposed, cannulated with a single-lumen bevelled 
micropipette, and perfused with 4% BSA-Ringer supplemented with low-density rat erythrocytes 
(as flow markers and source of S1P) at 60, 80 or 100cmH2O.  Vessels were intermittently and 
briefly occluded with a fine glass rod. Fluid filtration rate per unit area (JV/A) was calculated from 
the rate of erythrocyte movement towards the occluder and the cross-sectional area of the vessel. 
LP (x10-7 cm.s-1.cmH2O-1) was calculated from the slope of the relationship between filtration rate 
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and applied pressure, and the measured effective oncotic pressure difference (σΔπ) from the 
abscissal intercept. The ideal oncotic pressure of this perfusate (πc) was calculated empirically 
(Bates, 1998). Reflection coefficient was subsequently calculated from the relation 
 
Equation 2.2  σ = √(σΔπ/πc)  (Michel & Phillips, 1987).  
 
Measurements were repeated before and after perfusion with neuraminidase for 20-25min, 
matching apparent solute permeability experiments described above. 
 
Determination of true diffusive solute permeability 
Convective and diffusive fluxes of albumin contribute to the apparent solute permeability 
coefficient for albumin (PsBSA). The relative importance of these processes were discriminated 
using the recast form of the Patlak equation derived by Curry (Curry, 1984) and as subsequently 
expressed by Fu et al (Fu et al., 1998): 
 
Equation 3.1  ௦ܲ =  ௗܲ. ௉௘(௘ು೐ିଵ) + ܮ௣(1 − ߪ)∆P௘௙௙ 
 
where 
 
Equation 3.2  ܲ݁ = ௅೛(ଵିఙ)∆୔೐೑೑௉೏  
 
and 
 
Equation 3.3  ∆P௘௙௙ =  ∆P − σୟ୪ୠ∆Π௔௟௕ 
 
where Pd represents the true solute diffusive permeability coefficient for albumin across the 
vascular wall, and Pe is the Peclet number (ratio of convective to diffusive flux).  
 
 
Statistical analysis 
All statistics were calculated using Prism (GraphPad) software. Statistical significance was 
considered positive when a p value of <0.05 had been demonstrated. Unless otherwise 
expressed, all data are presented as mean ± standard error of the mean (SEM). All n values 
represent the number of animals used unless otherwise stated. Two-sided parametric tests were 
employed for analysis of true value estimates of glycocalyx parameters and PsBSA in vivo as well 
as glycocalyx depth measured from electron micrographs and the following statistical tests were 
employed: Pearson’s rank for examination of correlation, paired t-test, two-way ANOVA, and one-
way ANOVA were used for paired experiments; unpaired t-tests were used for unpaired 
comparisons. All post-hoc analyses used Bonferonni post-tests 
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RESULTS 
 
Endothelial glycocalyx 
Estimates of endothelial glycocalyx depth made in vessels perfused with R18 and FITC-WGA 
using the FWHM method yielded significantly higher measurements (1507 ± 136.9 nm, n = 10) 
than those determined in the same vessels using the peak to peak method of analysis (243.6 ± 
22.44 nm, n = 10) (p<0.001, paired t-test; Figure 3A). Using peak-to-peak measurements the 
fraction of vessel wall yielding positively resolvable glycocalyx measurements was 0.77 ± 0.04 (n = 
10) and the mean peak If of FITC-WGA across vessel walls was 176.4 ± 21.17 (n = 10). As the 
peak If of FITC-WGA signal increased, the paired peak to peak depth of endothelial glycocalyx 
significantly decreased, indicating that the peak If of FITC-WGA may be influencing the anatomical 
location of the peak If of R18, thereby resulting in a reduction in peak-to-peak endothelial 
glycocalyx depth estimates (p<0.05 by Pearson’s correlation, r = -0.6975; Figure 3B) 
 
Endothelial glycocalyx depth measured in vivo using both analysis methods (peak to peak and 
FWHM) were compared with the depth of endothelial glycocalyx measured at the same anatomical 
site of the same vessel ex vivo from paired electron micrographs. Paired comparisons 
demonstrated that endothelial glycocalyx depth estimated with FWHM (1376± 99.77 nm, n = 5) 
(Figure 3C) and peak to peak (243.6 ± 22.44, n = 5) (Figure 3D) techniques both yielded 
significantly greater estimates of depth than that estimated from paired electron micrographs 
(78.09 ± 16.16 nm, n = 15) (p < 0.001, paired t-test). Endothelial glycocalyx depth measurements 
were therefore 3.1 - 17.6-fold greater using confocal microscopy in vivo than measurements at the 
same site using electron microscopy ex vivo, with the broad range dependent on the method used 
to analyse the confocal microscopy images. 
 
Measurements of glycocalyx depth for TRITC-WGA and TMA-DPH peak-to-peak (622.7 ± 67.18 
nm n = 5) methods were, on average, significantly greater than the previous depth estimates for 
FITC-WGA and R18 peak-to-peak (231.4 ± 24.4 nm, n = 6, P < 0.001 by unpaired t-test) (Figure 
3E). Fractional coverage by resolvable endothelial glycocalyx was not significantly different using 
the two sets of fluorescent labels (TMA-DPH, TRITC-WGA: 0.7867 ± 0.03851, n = 5; R18, FITC-
WGA: 0.7028 ± 0.04291, n = 6) (P > 0.05 unpaired t-test) (Figure 3F). Peak fluorescence intensity 
measurements were also not significant different between TRITC-WGA (269.0 ± 109.5 grayscale 
units n = 5) and FITC-WGA (123.6 ± 22.30 n = 6 grayscale units) (P > 0.05 unpaired t-test) (Figure 
3G). Unlike the significant relation between endothelial glycocalyx depth measured with the peak-
to-peak method and the peak If of FITC-WGA signal, there was no significant relation between 
peak-to-peak determined glycocalyx depth and the peak If of TRITC-WGA signal (r = 0.29, p >0.5 
Pearson’s correlation). 
 
Apparent solute permeability 
To test the assumption of a linear relationship between the number of Alexa488-BSA molecules in 
a perfused vessel with the mean If measured in that same vessel in vivo (Equation 1.5), individual 
vessels were imaged during consecutive perfusion with the following concentrations of Alexa 488 
BSA: 0 mg/ml, 0.003 mg/ml, 0.015 mg/ml, 0.03 mg/ml, 0.15 mg/ml, and 0.3 mg/ml of Alexa 488 
BSA. There was a significant linear relationship between the number of Alexa Fluor 488 BSA 
molecules and the mean If measured within the perfused vessel (r2 = 0.9916, P < 0.0001, 
Pearson’s correlation) (Figure 4A, B). There was no significant difference between PsBSA estimates 
made using these different concentrations of Alexa488-BSA in the same microvessel (P > 0.05 by 
one-way ANOVA) (Figure 4C). 
 
Importance of endothelial glycocalyx sialic acids 
To determine whether endothelial glycocalyx sialic acids contribute to endothelial glycocalyx 
structure and vessel wall permeability, endothelial glycocalyx parameters and solute permeability 
were measured in individual vessels before and after (or with and without) disruption of terminal 
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sialic acids by perfusion with neuraminidase. With the peak to peak method of analysis, there was 
no significant difference between glycocalyx depth at baseline (243.6 ± 22.44 nm, n = 10) and that 
measured after 20 minutes of treatment with vehicle (231.4 ± 24.4 nm, n = 6) (p > 0.05, two-way 
ANOVA Bonferroni post hoc analysis) (Figure 5A), but glycocalyx depth was significantly reduced 
within single vessels after 20 minutes of treatment with neuraminidase (185.0 ± 32.78 nm) when 
compared to baseline (288.9 ± 28.74 nm) (p < 0.01, n = 5, two-way ANOVA Bonferroni post hoc 
analysis) (Figure 5B). The technique with the peak-to-peak method of analysis was sufficiently 
sensitive to detect changes in endothelial glycocalyx depth in unpaired comparisons of vehicle- or 
neuraminidase-perfused vessels labelled with TRITC-WGA and TMA-DPH (rather than FITC-WGA 
and R18, as described above) (vehicle treatment: 622.7 ± 67.18 nm; neuraminidase treatment: 
386.3 ± 10.82 nm; p < 0.05, unpaired t-test) (Figure 5C). 
 
Removal of sialic acid residues with 20 minutes of treatment with neuraminidase also reduced the 
depth of endothelial glycocalyx as determined by the FWHM method of analysis (1646 ± 352.6 
nm, n = 5, at baseline; 1223 ± 199.4 nm, n = 5, after neuraminidase) (p < 0.05, n = 5, two-way 
ANOVA Bonferroni post hoc analysis), with no significant change in endothelial glycocalyx depth 
as determined by the FWHM method when vessels were treated with vehicle (1479 ± 68.81 nm) 
compared to baseline (1355 ± 84.03 nm) (p > 0.05, two-way ANOVA Bonferroni post hoc analysis) 
(Figure 5D,E). Unpaired comparisons (TRITC-WGA and TMA-DPH) of FWHM measure of 
glycocalyx depth did not have sufficient discrimination to demonstrate a significant reduction in 
glycocalyx depth following treatment with neuraminidase (1492 ± 116.8 nm) when compared to 
vehicle treated control (1265 ± 150.5 nm) (P > 0.05 by unpaired t-test) (Figure 5F). 
 
The fluorescence intensity of FITC-WGA (If) was not significantly altered after perfusion for 20 
minutes with vehicle (123.6 ± 22.30, n = 6) when compared to that measured at baseline (176.4 ± 
21.17, n = 10) (p > 0.05, two-way ANOVA Bonferroni post hoc analysis) (Figure 5G), but was 
significantly reduced following 20mins of neuraminidase perfusion (124.9 ± 13.53) when compared 
to that imaged at baseline (460.9 ± 48.21) (n = 5, p < 0.001, two-way ANOVA Bonferroni post hoc 
analysis). (Figure 5H). Unpaired comparisons of peak If of TRITC-WGA did not have sufficient 
discrimination to demonstrate a statistically significant change to glycocalyx staining intensity 
following treatment with neuraminidase (95.63 ± 24.53 nm) when compared to the vehicle treated 
control (269.0 ± 109.5 nm) (p > 0.05 by unpaired t-test) (Figure 5I).  
 
The proportion of vessels with a glycocalyx depth greater than zero (fractional coverage), 
determined using the peak-to-peak method, was unchanged from baseline coverage (0.7650 ± 
0.02563, n = 10) after perfusion of vehicle (0.7028 ± 0.04291, n = 6) (p > 0.05, two-way ANOVA 
Bonferroni post hoc analysis), and likewise was unchanged before (0.8500 ± 0.07397, n = 5) and 
after perfusion with neuraminidase (0.8167 ± 0.05603, n = 5) (p > 0.05, two-way ANOVA 
Bonferroni post hoc analysis) (Figure 5J and K). Unpaired comparisons (using TRITC-WGA and 
TMA-DPH) did reveal a significant reduction in glycocalyx fractional coverage following 
neuraminidase treatment (0.57 ± 0.07) when compared to the vehicle treated control (0.79 ± 0.04) 
(p < 0.05 by unpaired t-test) (Figure 5L). 
 
Measurement of endothelial glycocalyx depth within electron micrographs revealed a significant 
reduction in glycocalyx depth for vessels treated with neuraminidase (40.01 ± 7.317 nm, n = 7) 
when compared to vessels treated with vehicle alone (78.09 ± 16.16 nm, n = 5) (p <0.05, by 
unpaired t-test) (Figure 5M). The depth of the endothelial glycocalyx determined in vivo from peak-
to-peak analysis demonstrated a significant positive linear relationship to the depth estimates of 
the endothelial glycocalyx in the same vessels using electron micrographs (r = 0.7515, p < 0.05, 
Pearson’s correlation, 9 pairs) (Figure 5N). However, none of the other measurements of 
endothelial glycocalyx parameters obtained from confocal microscopy images (peak If, fractional 
coverage) correlated with the endothelial glycocalyx depth measurements from electron 
microscopy images (FWHM: r = 0.1362, n = 9 pairs, p > 0.05 Pearson’s correlation; peak If: r = -
0.5184, n = 9 pairs, p > 0.05 Pearson’s correlation; fractional coverage: r = -0.2734, n = 9 pairs, p 
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> 0.05 Pearson’s correlation). 
 
Treatment of perfused microvessels with vehicle solution for 20-25mins did not significantly alter 
PsBSA (from 4.0±0.43 x10-6 cm.s-1 to 2.6±0.44 x10-6 cm.s-1; n=5 pairs; p>0.05, two-way ANOVA with 
Bonferroni’s correction), but disruption of sialic acids with neuraminidase treatment did significantly 
increase PsBSA 6.8-fold (from 3.5±1.0 x10-6 cm.s-1 to 23.8±8.3 x10-6 cm.s-1 to; n=4 pairs; p <0.001 
by two-way ANOVA) (Figure 6A). The rise in permeability in response to neuraminidase treatment 
was progressive and linear (r2 0.9216; p <0.01, Pearson’s correlation) (figure 6B). There was a 
significant inverse linear relationship between PsBSA and endothelial glycocalyx fractional coverage 
in the same vessels in neuraminidase-treated and vehicle-treated vessels (r = -0.731, n = 9 pairs, 
p < 0.05 Pearson’s correlation) (figure 6C). Likewise there was an inverse relationship between 
PsBSA and endothelial glycocalyx depth as assessed by the peak-to-peak analysis of TRITC-WGA 
in the same vessels in neuraminidase-treated and vehicle-treated vessels, (r = -0.80, p < 0.05 by 
Spearman’s correlation) but this relationship was not linear (best fit: single one phase decay curve; 
depth = 330nm + 607nm x e -0.38xPs) (figure 6D). 
 
Over the same time course, disruption of sialic acids with neuraminidase treatment also 
significantly increased hydraulic conductivity by 1.9-fold (baseline: 1.39±0.32 x10-7 cm.s-1.cmH2O-1; neuraminidase: 2.68±0.81 x10-7 cm.s-1.cmH2O-1; n=7 pairs; p < 0.05, Wilcoxon) (Figure 6E) and 
significantly reduced reflection coefficient (baseline: 0.96±0.01; neuraminidase: 0.87±0.03; n = 7 
pairs, p < 0.05, paired t-test) (Figure 6F). 
 
Using measured and calculated parameter values (PsBSA , Lp,  σ, πBSA) from these experiments, 
and calculating Peclet number for these experiments (equation 3.1), true diffusive BSA solute 
permeability coefficient values (Pd) were 7-fold and significantly increased by disruption of sialic 
acids by neuraminidase treatment (3.38 x10-6 cm.s-1 under baseline conditions; 2.41 x10-5 cm.s-1 
after neuraminidase treatment; p<0.001, unpaired t-test) (figure 6G).  
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DISCUSSION 
 
In this study we have successfully developed methods for paired, real-time, direct in vivo 
assessment of endothelial glycocalyx structure and dependent microvascular function 
(permeability). These techniques demonstrate that measurements of the depth of endothelial 
glycocalyx are highly dependent on the labelling, detection and analysis methods employed, and 
vary by more than an order of magnitude. Highest values are obtained by full-width half-maximum 
analysis of fluorescently-labelled WGA-lectin binding to the endothelial glycocalyx, and lowest 
values are obtained from electron micrographs of alcian blue-labelled endothelial glycocalyx from 
the same vessel. Estimating the anatomical distance between peak signals from endothelial 
glycocalyx and endothelial cell membrane labels with distinct fluorescence emission spectra 
provides the most sensitive and reliable measure of endothelial glycocalyx depth. Sialic acid 
residues within the endothelial glycocalyx regulate glycocalyx structure, as well as the permeability 
of the vessel wall to both water and albumin. Neuraminidase-induced changes in glycocalyx 
structure (by fluorescence and electron microscopy) correlated with changes in transvascular 
solute flux. 
 
Sialic acids cap a range of glycoproteins within the endothelial glycocalyx (e.g. (Varki, 2008)) and 
are present at high density on the endothelial cell surface (<50 x106/um2: (Born & Palinski, 1989), 
including in human microvessels (Tatsuzuki et al., 2009), and are potentially found at increased 
density at the endothelial cell surface adjacent to the dominant route for water and solute flux 
across the vessel wall: interendothelial clefts (Bai & Wang, 2014).The current studies demonstrate 
that disruption of sialic acid residues within the endothelial glycocalyx reduces the degree of 
reflection of albumin by the microvessel wall, and increases the conductance of water, and 
therefore sialic acid residues within the endothelial glycocalyx are principal regulators of 
microvessel permeability. 
 
These findings are in direct conflict with the only other investigation of the effect of sialic acid 
disruption on true permeability coefficients in vivo (Mason et al., 1977), in which neuraminidase 
had no effect on mesenteric microvessel hydraulic conductivity. Whilst it is possible that species 
differences (frog vs rat) account for this difference, the highly conserved nature of endothelial sialic 
acid expression (Aamelfot et al., 2014) argues against this possibility. We suggest that it is more 
likely that temperature differences (frog ~15°C; rat 37°C) permit greater enzyme activity and hence 
greater degree of sialic acid disruption in the current study, thereby revealing an important role of 
sialic acids in regulating permeability. The previous study in frogs did not perform paired labeling 
of glycocalyx or other ultra-structural components, and thus active changes in structure assumed 
to be brought about by neuraminidase were not confirmed (Mason et al., 1977) as they have been 
here. 
 
Other evidence supporting the concept of sialic acids regulating microvascular permeability arise 
from systems in which the measures of permeability coefficients are confounded by the model 
used or by unregulated variables. For example, disruption of endothelial glycocalyx sialic acids 
with neuraminidase was shown to increase permeability and reduce glycocalyx depth of 
endothelial cells in vitro (Singh et al., 2007; Cioffi et al., 2012). Whilst cultured endothelial cells 
display permeability coefficients that are orders of magnitude greater than those observed in intact 
vessels in vivo (Curry, 2005), and possess an endothelial glycocalyx that differs substantially from 
that observed on intact vessels (Chappell et al., 2009), these findings are consistent with the 
demonstrated importance of sialic acids in regulating multiple permeability coefficients in vivo in 
the current report. Investigations into the effects of neuraminidase on water and albumin flux in 
other microvessel beds support our findings that true microvessel wall permeability coefficients are 
regulated by sialic acid residues. One such study observed alveolar oedema formation within 
isolated-perfused lungs from rats treated with neuraminidase (0.5 U/ml for 30 minutes) 
demonstrating an ~8 fold increase in transvascular perfusate flux (calculated from the change in 
organ weight at different perfusion pressures) indicating that sialoglycoproteins expressed within 
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the endothelial glycocalyx of pulmonary microvessel beds may influence solute and water flux 
(Cioffi et al., 2012). Since sialic acids also regulate glycocalyx-mediated mechanotransduction 
(Tarbell & Pahakis, 2006) and consequent vessel dilation (Kumagai et al., 2009), observed 
increases in solute or water flux following neuraminidase treatment (Cioffi et al., 2012; Salmon et 
al., 2012) may represent a vasodilation-induced increase in the hydrostatic forces driving solute 
and water flux rather than a true change in the permeability of the vessel wall. The current studies 
confirm that, over-and-above regulating vessel diameter and hence the magnitude of Starling 
forces driving solute and fluid flux, sialic acids also regulate the permeability of microvessel walls. 
 
There are a number of biophysical and biochemical mechanisms through which sialic acids may 
regulate microvascular permeability. The contribution of the endothelial glycocalyx to hydraulic 
permeability is thought to be imparted largely through glycocalyx depth (Adamson, 1990), with a 
reduction in glycocalyx thickness sufficient to explain increased hydraulic conductivity, as 
observed in response to sialic acid disruption here. The endothelial glycocalyx has been 
calculated to contribute approximately 60% to the hydraulic resistance of the vessel wall 
(Adamson et al., 2004). The ~2-fold increase in hydraulic conductivity following neuraminidase 
treatment is comparable to the ~2.5-fold increase in hydraulic conductivity following pronase 
treatment of frog mesenteric microvessels (Adamson, 1990), and also similar to the ~2.3-fold 
increase in hydraulic conductivity observed in rats with spontaneous proteinuric chronic kidney 
disease and reduced glycocalyx depth (Salmon et al., 2012). The relationship between glycocalyx 
depth and albumin permeability has been less clear: the non-linear relation between these 
parameters indicated here (figure 6D) illustrates one possible aspect of that relationship. The 
presence of glycocalyx after neuraminidase treatment with a reduction in thickness of a similar 
relative level (60% for confocal, 50% for electron microscopy) suggests that the glycocalyx needs 
to reach a minimal depth before being able to impede albumin flux. Alternative explanations 
include a potential change in glycocalyx coverage in critical permeability-determining regions, such 
as in microdomains overlying interendothelial clefts. Furthermore, since other structural and 
biological aspects of the glycocalyx (such as 3D ultrastructure and electrical charge) have not 
been assessed with these techniques, parameters other than depth and spatial distribution may 
also impact on the relationship between glycocalyx structure and albumin permeability. This could 
be further investigated with more information on the structure of the glycocalyx, such as that 
generated using complex staining techniques (Arkill et al., 2011) to be able to build testable 
models of how the glycocalyx regulates albumin permeability. 
 
The observed reduction in endothelial glycocalyx thickness is unlikely, however, to explain the 
observed reduction in reflection coefficient. Molecules are reflected back into the vessel lumen 
during convective drag because the functional pore aperture, determined by the combination of 
steric and electrochemical pore properties, is too small to allow large solute molecules (such as 
BSA) to pass. The ordered lattice-like structure of the endothelial glycocalyx imparts efficient 
molecular sieving properties (Arkill et al., 2011), with the arrangement, dimensions and charge of 
the individual fibres of the lattice all dictating the efficiency with which solutes are reflected back 
into the vessel lumen under conditions of convective flux (Hu et al., 2000; Squire et al., 2001; 
Weinbaum et al., 2003; Arkill et al., 2011). Membrane-bound components of the endothelial 
glycocalyx display the necessary quasi-ordered arrangement to contribute to this ordered lattice 
(Squire et al., 2001), raising the possibility that sialic acid-capped, membrane-bound glycoproteins 
and/or proteoglycans may be important in regulating the molecular sieving and hence the 
reflection coefficient of microvessel walls. For example, sialic acid-depleted glycoproteins may 
form a pore that provides less resistance to the passage of albumin molecules because of reduced 
net negative charge on the fibres surrounding the pore, thereby facilitating the passage of 
negatively charged albumin molecules through the pore. However, removal of sialic acid residues 
did not significantly alter the surface charge of endothelial cells (Vargas et al., 1989), and hence 
the neuraminidase effect observed here may be steric rather than electrochemical, through 
altering the shape, size or interactions between sialic acid capped molecules that comprise the 
pore. Combining the current structure-function studies with a glycan-specific electron dense labels 
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(e.g. gold particle-labelled lectins - (Baldwin & Winlove, 1984)) and fourier transformation analysis 
to investigate changes to the ordered arrangement of sialic acid residues within the endothelial 
glycocalyx may be informative in this regard.  
 
Sialic acid disruption might also (or alternatively) result in secondary changes within the 
endothelial glycocalyx, thereby altering permeability coefficients. For example, re-arrangement or 
activation of glycocalyx-embedded receptors or inter-endothelial cleft molecules such as VE-
cadherin may follow sialic acid disruption (Geyer et al., 1999). However, re-organisation of the 
interendothelial cleft molecules occurs hours after sialic acid disruption (Cioffi et al., 2012), more 
slowly than both the increase in permeability and the change in endothelial glycocalyx 
measurements observed over minutes in these studies. Direct modification of the endothelial 
glycocalyx therefore appears to be a more likely explanation for the changes in permeability 
measured here. Disrupting the interaction between sialoglycoproteins-based arginine residues and 
albumin molecules may have reduced the adsorbed fraction of albumin within the endothelial 
glycocalyx, reducing albumin-dependent sphingosine-1-phosphate signalling leading to active 
shedding of other glycocalyx (Adamson et al., 2012; Curry et al., 2012; Curry & Adamson, 2013; 
Zeng et al., 2013; Adamson et al., 2014). However, these secondary changes again point to an 
important role for sialic acid residues within the endothelial glycocalyx in regulating microvessel 
permeability. 
 
These simultaneous changes in microvessel permeability and endothelial glycocalyx structure 
have been revealed through novel techniques that permit examination of microvessel permeability 
coefficients as well as real-time confocal microscopy and post-hoc electron microscopy 
examinations of the endothelial glycocalyx covering the same portion of the same vessel. 
Neuraminidase-induced changes in the endothelial glycocalyx structure identified with confocal 
microscopy correlated with parallel changes in the endothelial glycocalyx measured from electron 
micrographs of the same portion of the same vessel in vivo. A number of processing steps are 
required to visualise the endothelial glycocalyx by electron microscopy, including albumin-free 
perfusion prior to Alcian Blue labelling, glutaraldehyde fixation, and dehydration steps, each of 
which may affect glycocalyx appearance in electron micrographs. Nevertheless, the findings from 
the current report provide confidence that, at least under the conditions reported here, changes in 
the structure of the endothelial glycocalyx observed by standard electron microscopy techniques 
correlate well with both direct imaging of the endothelial glycocalyx in vivo (i.e. pre-EM processing) 
and with the function of the vessel wall. 
 
The absolute value of endothelial glycocalyx depth measurements with this method is within the 
range reported by others using a variety of techniques (for review see (Curry & Adamson, 2012)), 
but above the theoretical maximum threshold depth compatible with the demonstrated hydraulic 
conductivity of vessel walls (Curry & Adamson, 2013). Importantly, different analysis methods of 
the same lectin-labelled images generated a 6-fold range of glycocalyx depth measurements 
(FWHM to peak-to-peak methods), and the same analysis technique using different membrane 
and glycocalyx labels (peak-to-peak techniques) generated a ~2.5-fold range of glycocalyx depths. 
Even the lowest estimate of glycocalyx depth from confocal images was ~3-fold greater than depth 
assessed from electron micrographs. Clearly the method used to estimate glycocalyx depth has a 
large impact on the absolute value of endothelial glycocalyx depth reported, even when multiple 
assessments are made on the same vessel under identical conditions. This makes it difficult to 
compare studies using varied methodologies to judge whether there are true differences in the 
endothelial glycocalyx between different vessel beds. These findings suggest that quantifying 
relative changes in glycocalyx depth in response to individual experimental manipulations under 
identical experimental conditions may be more reliable than interpreting the absolute depth of the 
endothelial glycocalyx from varied techniques.  
 
Nevertheless, the peak-to-peak method, based on the anatomical distance between the peak 
endothelial plasmalemmal signal and the peak glycocalyx-bound lectin signal, [1] enabled 
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discrimination of neuraminidase-induced changes in confocal-determined glycocalyx depth 
measurements under paired and unpaired conditions, [2] with different glycocalyx and membrane 
labels, [3] correlated well with changes in endothelial glycocalyx depth measured by electron 
microscopy, [4] and correlated with changes in vessel wall function, thereby proving the most 
sensitive and reliable real-time in vivo method for quantifying changes in the endothelial 
glycocalyx. The choice of glycocalyx and endothelial cell membrane labels for these peak-to-peak 
assessments included FITC-WGA/R18, with demonstrated limitations including fluorescence 
emission signal bleed through and interactions between the magnitude of fluorescence signal and 
glycocalyx depth. TRITC-WGA/TMA-DPH assessments did not suffer from either these theoretical 
or measurement errors, but the variability of peak fluorescence signal was greater and will benefit 
from assessment in larger sample sizes. Peak to peak measurements were preferred over full-
width half-maximum measurements, as previous studies have indicated the presence of lectin 
binding to sialic acid residues on the abluminal side of the endothelial cell (e.g.(Oltean et al., 
2015)) that broaden the resulting fluorescent signal to generate falsely-elevated estimates of 
"endothelial glycocalyx" depth. Failing to discriminate between luminal and abluminal surface 
glycocalyx components may have contributes to some of the higher values for glycocalyx depth 
reported in the literature, particularly in the absence of simultaneous imaging of the endothelial cell 
surface (Yen et al., 2012). Full-width half-maximum, peak fluorescence intensity and fractional 
coverage analysis methods were not capable of discriminating neuraminidase-induced changes in 
the endothelial glycocalyx reliably (e.g. in paired and unpaired studies); none correlated with 
changes by electron microscopy; and neither peak fluorescence intensity or full width half 
maximum measurements correlated with changes in solute permeability; indicating that 
comparative assessment of glycocalyx signal relative to the endothelial cell surface is an important 
facet of measuring glycocalyx depth.  
 
These direct labelling methods for quantifying the endothelial glycocalyx are an important 
complement to indirect methods of glycocalyx assessment, in which the distance of a luminal 
tracer (electron-dense lipid droplets, fluorescently-labelled circulating molecules or microparticles, 
circulating cells) from the vessel wall is assumed to represent an impenetrable depth of endothelial 
glycocalyx. Many such methods need to take into account partial permeation of the tracer into the 
endothelial glycocalyx (Michel & Curry, 2009), as well as the influence of the glycocalyx on the 
spatial profile of substances flowing through the vessel (Pries et al., 1997). As such, changes in 
haemodynamics as well as changes in the endothelial glycocalyx could impact on the distance of 
the tracer from the vessel wall, thereby confounding the assumption that this distance represents 
the depth of the endothelial glycocalyx. Stop-flow studies (Haraldsson, 2014) and studies on small 
diameter vessels (Damiano, 1998) have been employed to overcome this confounding influence. 
Direct glycocalyx labelling methods reported here complement the critical in vivo assessments of 
glycocalyx-dependent vascular functions. These considerations are also important because of the 
recent spread of indirect methods of estimating endothelial glycocalyx depth into the clinical arena 
(Lee et al., 2014), using technologies that are not designed to directly measure the anatomical 
location of the vessel wall and therefore can only estimate a non-perfused boundary region. 
Validation studies coupling these potentially revolutionary clinically-applicable methodologies with 
direct assessment of the endothelial glycocalyx are warranted.  
 
Our study has a number of potential limitations. Neuraminidase cleaves the O-glycosidic linkages 
between the terminal neuraminic (sialic) acids and the subterminal sugars (Cassidy et al., 1965), 
but almost all enzymatic manipulations of endothelial glycocalyx components are prone to direct 
but off-target enzymatic disruption of other components of the endothelial glycocalyx (Tarbell, 
2010). Neuraminidase removes <5% of other components of the endothelial glycocalyx (Pahakis 
et al., 2007). Wheat germ agglutinin lectin also labels N-acetyl-glucosamine residues within 
various glycosaminoglycans, although more than 60% of WGA-labelled structures are sialic acids 
(Barker et al., 2004). Overall, the >95% specificity of neuraminidase and >60% specificity of WGA 
for sialic acid residues indicates that no more than 2% of the observed reduction in WGA signal 
after neuraminidase treatment is likely to be due to an effect on other glycocalyx structures. 
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Three parameters of microvascular permeability were measured in rat mesenteric microvessels 
under identical experimental conditions before and after exposure to neuraminidase, but true 
permeability coefficients (hydraulic conductivity and reflection coefficient) were measured in 
different vessels from those in which measurements of endothelial glycocalyx were made. This 
represents a technical limitation, since different microscopes were required for confocal and light 
microscopy studies, and it was not practical to maintain anaesthesia and transport animals 
between rigs. Nevertheless there is good concordance amongst the results, and changes in 
apparent solute permeability in one set of experiments are explained by the observed changes in 
hydraulic conductivity and reflection coefficient observed in parallel experiments. Of note, 
however, is that despite this concordance the magnitude of the PsBSA values reported here 
(~2.8×10−6 cm.s-1 under normal and vehicle treated conditions) are greater than the ~0.4 to 
1.0×10−6 cm.s-1 measured in rat mesenteric microvessels by other researchers (Fu & Shen, 2004; 
Cai et al., 2012; Curry et al., 2012; Adamson et al., 2014). In contrast, hydraulic conductivity 
values (1.39 x10-7 cm.s-1.cmH2O-1) are in the range reported previously (1.2 - 2.43 x10-7 cm.s-1.cmH2O-1: (Kendall & Michel, 1995; Michel & Kendall, 1997; Curry et al., 2003; Salmon et al., 
2009; Curry et al., 2012) as are reflection coefficient values (0.96; e.g. 0.94: (Kendall & Michel, 
1995)). This suggests that technical factors relating to the PsBSA experiments may be responsible 
for these higher PsBSA values, such as reduced S-1-P content of erythrocyte-free perfusate in PsBSA 
and glycocalyx imaging studies (necessitated by the use of narrow-lumen double-barrelled theta 
pipettes in contrast to erythrocyte-containing perfusate in hydraulic conductivity / reflection 
coefficient studies (Curry et al., 2012)), or an influence of the alexa-488 label applied to BSA (as 
demonstrated for other fluorescent labels: (Bingaman et al., 2003)). Low S1P conditions may 
compromise glycocalyx and intercellular junction integrity, affecting baseline permeability states, 
and this hinders detailed biophysical interpretation of sialic acid-regulated pathways for 
transvascular passage of albumin. 
 
The perfused single vessel methodology adopted here has also been critiqued in the literature. 
However, single vessel perfusion permeability techniques have been described as the "squid giant 
axon" of permeability studies (Curry, 2005): the current report extends their utility to real-time in 
vivo structure-function assessments of the endothelial glycocalyx as a complement to the range of 
other microvascular endothelial glycocalyx studies already available or in development.    
 
Given the widespread importance of the endothelial glycocalyx for normal physiology and a broad 
number of disease states, we have expanded the range of techniques that permit direct studies of 
the structure of the endothelial glycocalyx, as well as dependent microvascular functions. Through 
these novel techniques, we demonstrate that sialic acid residues within the endothelial glycocalyx 
are critical regulators of microvascular permeability to both water and albumin. 
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FIGURE LEGENDS  
 
Figure 1. Imaging and analysis of endothelial glycocalyx in vivo 
 
A. Section of a z-stack imaged in vivo; when a measurement line was drawn across the width of a vessel, all 
available slices (blue arrows) were scanned though and the slice which yielded the widest vessel diameter 
(red arrow) was selected for measurements. B. Example of FITC-WGA (green) and R18 (red) imaged vessel 
in the mid-plane region. For demonstration purposes the intensity profile (yellow arrow) has only been 
drawn on one side of the vessel; this line was actually drawn across the entire width and therefore took 
measurements of both sides simultaneously. C. The intensity profile of both R18 and FITC-WGA along a 
line across the vessel wall (yellow arrow) was used to determine 4 parameters of glycocalyx depth; 1) the 
anatomical distance between peak signals from R18 and FITC-WGA labels (peak-to-peak: P-P) as a 
measure of depth, 2) the full width measured at the point of half maximal fluorescence intensity of FITC-
WGA (FWHM), and 3) and the peak intensity of FITC-WGA (If). 4) fractional coverage of endothelial 
glycocalyx was calculated as the number of points with a peak-to-peak endothelial glycocalyx depth 
measurement >0. D. A model of endothelial glycocalyx (green bar) was moved (white arrow) at 1nm 
intervals across an Airy disc representation of laser light (white circle). Scale bar: 100nm. E. the 
fluorescence intensity (If) of measurements across the green bar (green points) was highest when peak If was 
calculated by triangulation (interrupted straight blue lines, blue arrows), lowest from absolute values (green 
points and arrows), and intermediate when peak If was calculated from a Gaussian distributions 
(interrupted black curve, black arrows). 
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Figure 2. Paired imaging of solute permeability and endothelial glycocalyx in single 
microvessels 
 
A. Two 26G needles (n) and two fine tubes (grey line) were inserted into each of the main barrels of the 
beveled theta style micropipette (TP) and glued in place to form a tight seal. Two syringe pumps (sp) were 
used to push solution into the fine tube which was connected to the pump by a refill line (r) and both sides 
filled with BSA-Ringer (or desired dye). The other end of the syringe pumps (sp) were connected to a waste 
line (w) that was positioned directly behind the back of the two needles (n) and would pull solution away 
(green arrows) as the refill line pushed solution into (black arrows) the pipette. The needles were also 
connected to a two separate water manometers; the right manometer (rm) and the left manometer (lm) to 
control pressure on each side of the pipette independently. This design allowed the solution in the pipette to 
be readily changed even during microvessel cannulation. B. Mesenteric microvessels of pentobarbitone-
anaesthetized male Sprague Dawley rats were cannulated using theta style micropipettes where the pressure 
on either side was set so that only one desired side perfused (15-30cm of H2O). Perfused BSA-Ringer was 
switched instantly to perfused Alexa 488 labelled BSA (0.03mg/ml) transiently for 30 to 60 seconds, and 
imaged using fluorescent microscopy C. A measuring window is drawn across the vessel and areas 
surrounding it and the change in mean fluorescence intensity (If) is plotted against time (t). Initial filling of 
the vessel with Alexa 488 labelled BSA causes a stepwise increase in If (ΔIf0), followed by a steady linear 
increase in If,, the initial rate of change of which ([dIf/dt]0) represents the rate of solute flux across the 
vessel wall D. Confocal image of cannulated mesenteric microvessel perfused and labelled with TMA-DPH 
(endothelial cell membrane: blue) and TRITC-WGA (sialic acids within endothelial glycocalyx: red). vl: 
vessel lumen. int: interstitium. White bar: selected line of interest across vessel wall. E. Fluorescence 
intensity profile along selected white bar. P-P (peak to peak): measure of anatomical distance between peak 
fluorescence of TMA-DPH (endothelial cell membrane: blue) and TRITC-WGA (sialic acids within 
endothelial glycocalyx: red) signals. FWHM: measure of Full Width Half Maximum of TRITC-WGA (sialic 
acids within endothelial glycocalyx: red) signal. Other previously described parameters were also analyzed 
(mean peak If of TRITC-WGA, and fractional coverage). F representative images of the same cannulated 
and perfused microvessel imaged using light (i), confocal (ii) and electron (iii) microscopy. (i) P: pipette. I: 
interstitium. VL: vessel lumen. (ii) red: endothelial cell membrane (R18). Green: endothelial glycocalyx 
(FITC-WGA). White box: portion of membrane also examined by electron microscopy. (iii) VL: vessel 
lumen. EG: endothelial glycocalyx. ECM: endothelial cell membrane. EC: endothelial cell. I: interstitium.  
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Figure 3. Endothelial glycocalyx depth in an individual vessel varies by more than an order 
of magnitude, according to the imaging and analysis method  
 
A. Microvessels were imaged immediately after perfusion with FITC-WGA (glycocalyx) and R18 (cell 
membrane). A line was drawn across the full diameter of the vessel and the depth of the endothelial 
glycocalyx estimated from: the Full Width measured at the point of Half Maximal fluorescence intensity of 
FITC-WGA (FWHM); and the anatomical distance between peak signal from R18 (cell membrane) and 
FITC-WGA (sialic acids within endothelial glycocalyx) (peak to peak). FWHM analysis generated 
significantly higher values of glycocalyx depth than peak to peak analysis (***p < 0.001 paired t-test). B. 
The depth of the glycocalyx (peak-to-peak method) (y-axis) was inversely related to the peak fluorescence 
intensity (If) of FITC-WGA (x-axis) (r = -0.50, p<0.05 Pearson’s correlation). C. Full-Width Half Maximum 
(FWHM) measurements of endothelial glycocalyx depth made from confocal microscopy (CM) images were 
significantly greater than subsequent depth measurements of Alcian Blue-labelled endothelial glycocalyx 
imaged with electron microscopy (EM) in the same vessel (*** P<0.001 paired t-test). D. Peak to peak 
measurements of endothelial glycocalyx depth from confocal microscopy (CM) images were also 
significantly greater than measurements of Alcian Blue-labelled endothelial glycocalyx depth measurements 
from electron microscopy (EM) in the same vessel (*** p<0.001 paired t-test). E. Glycocalyx depth 
measurements made in TMA-DPH and TRITC-WGA-labelled vessels by the peak to peak method are 
significantly greater than peak to peak-determined endothelial glycocalyx depth measurements made in R18 
and FITC-WGA-labelled vessels (n = 6) (***p < 0.001 unpaired t-test). There is no significant difference 
between fractional glycocalyx cover (F) or peak WGA fluorescence intensity (If) (G) in TRITC-WGA-
labelled vessels and FITC-WGA-labelled vessels (all ns, p > 0.05 unpaired t-test).  
  
 29
Figure 4. Imaging and analysis of solute permeability in vivo 
 
A. The mean fluorescence intensity of Alexa Fluor 488 conjugated BSA (If: y-axis) was measured and 
quantified within a cannulated and perfused microvessel in vivo, and plotted against the concentration of 
Alexa Fluor 488 conjugated BSA being perfused (x-axis). The measured If is linearly related to the 
concentration of Alexa Fluor 488 conjugated BSA being perfused (r2 = 0.9916, p<0.0001 Pearson's 
correlation). B. An expanded plot of the lower range of If versus Alexa Fluor 488 conjugated BSA 
concentration data, demonstrating that this linear relation holds at the range of low concentrations of Alexa 
Fluor 488 conjugated BSA used in solute permeability experiments (0.03mg/mL) C. PsBSA was calculated in 
the same perfused microvessel in vivo perfused with different concentrations of Alexa Fluor 488 conjugated 
BSA (BSAAF488). There was no significant difference between the PsBSA values calculated from the If for each 
of these perfusates (ns, p = 0.9404, one way ANOVA).  
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Figure 5. Disruption of sialic acids reduces endothelial glycocalyx depth and coverage 
 
Endothelial glycocalyx parameters were determined in vessels with sialic acid disruption achieved by 
20mins perfusion with 40mg/ml BSA supplemented with 2U/ml neuraminidase (filled triangles), or in 
control vessels perfused with 40mg/ml BSA vehicle alone (baseline: filled circles; vehicle perfusion; filled 
squares). Glycocalyx depth determined using the peak to peak method of analysis was no different before 
and after perfusion with vehicle (A), but was significantly reduced after neuramindase perfusion (B) (ns: p 
> 0.05; ** p < 0.01, two-way ANOVA with Bonferroni post-hoc analysis). This neuraminidase-induced 
reduction in peak-to-peak determined measurements of endothelial glycocalyx depth was reproduced in 
unpaired experiments (C) in which endothelial glycocalyx depth was determined once only, after earlier 
measurements of solute permeability in the same vessel during perfusion with either 40mg/ml BSA vehicle 
alone (filled squares) or 40mg/ml BSA supplemented with 2U/ml neuraminidase (filled triangles) (*p < 
0.05, unpaired t-test). Likewise, glycocalyx depth determined with the Full Width Half Maximum (FWHM) 
method was unaltered by perfusion with vehicle solution (D), but was significantly reduced after 
neuraminidase perfusion (E) (ns: p > 0.05; ** p < 0.01, two-way ANOVA with Bonferroni post-hoc 
analysis). However, in separate measurements in which endothelial glycocalyx depth was measured only 
once by the FWHM after initial solute permeability measurements during perfusion with either 40mg/ml 
BSA vehicle alone (filled squares) or 40mg/ml BSA supplemented with 2U/ml neuraminidase (filled 
triangles), no significant difference was determined (ns, p > 0.05, unpaired t-test) (F). Identical results (as 
for FWHM) were also obtained when determining the peak If of WGA-labelled endothelial glycocalyx in 
paired (G,H; ns: p > 0.05; ** p < 0.01, two-way ANOVA with Bonferroni post-hoc analysis) and unpaired 
(I; ns, p > 0.05, unpaired t-test) experiments. The fractional coverage of the vessel wall with endothelial 
glycocalyx resolvable with the peak-to-peak method of analysis was no different before and after perfusion 
with either vehicle or neuraminidase (J,K; ns: p > 0.05, two-way ANOVA with Bonferroni post-hoc 
analysis), but a significant reduction was observed after neuraminidase perfusion in unpaired experiments 
(L; *, p < 0.05, unpaired t-test). Endothelial glycocalyx depth measured in electron micrographs was 
significantly lower in neuramindase-perfused vessels, as compared with vehicle-perfused vessels (*, p<0.05, 
unpaired t-test) (M). There was a significant positive correlation between the depth of endothelial 
glycocalyx determined in electron microscopy (EM) images with the depth of endothelial glycocalyx 
determined by the peak-to-peak analysis method in confocal microscopy (CM) images in the same vessel (N; 
r = 0.75, p < 0.05 Pearson correlation). 
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Figure 6. Disruption of sialic acids increases microvascular permeability to water and 
albumin 
 
A. Apparent solute permeability to albumin (PsBSA) was measured in microvessels before (baseline) and 20-
25min after (treatment) perfusion with either vehicle (filled bars) or neuraminidase (open bars). Sialic acid 
disruption with neuraminidase perfusion significantly increased PsBSA (*, p < 0.05, two-way ANOVA post 
hoc Bonferroni analysis), with no significant change in PsBSA in vehicle-perfused control vessels (ns, p > 
0.05, two-way ANOVA post hoc Bonferroni analysis). B. PsBSA increased progressively over time during 
neuraminidase perfusion (filled triangles), but remained unaltered during vehicle perfusion (filled squares). 
A significant increase in PsBSA was noted after 15-20 minutes treatment with neuraminidase, matching the 
timecourse of neuraminidase-induced endothelial glycocalyx disruption (***, p <0.001, two-way ANOVA, 
Bonferroni post-hoc analysis). A significant inverse correlation was noted between PsBSA and fractional 
coverage by resolvable endothelial glycocalyx determined with the peak-to-peak method (C) (r = -0.73, p < 
0.05 Pearson correlation). A significant relation between PsBSA and endothelial glycocalyx depth determined 
with the peak-to-peak method was best described by a single one phase decay curve with a relationship of 
depth = 330nm + 607nm x e -0.38xPs (D). Microvessel hydraulic conductivity (LP) was significantly increased 
after sialic acid disruption with 20-25min perfusion with neuraminidase (filled triangles) compared with 
baseline measurements in the same vessel (filled circles) (*, p < 0.05, Wilcoxon) (E). Microvessel reflection 
coefficient to albumin was significantly reduced after sialic acid disruption with 20-25min perfusion with 
neuraminidase (filled triangles) compared with baseline measurements in the same vessel (filled circles) (*, 
p < 0.05, Wilcoxon) (F). There was a significant increase in true diffusive solute permeability to albumin 
after sialic acid disruption with neuraminidase (*, p < 0.001, unpaired t-test) (G). 
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